Westlake Omics completes tens of millions of RMB in seed funding to advance proteomics research and precision-assisted diagnostics
Dedicated to realizing proteomics-based precision medicine, advancing auxiliary diagnosis of major human diseases.
高榕创投
@gaorong
创造美好生活
531 articles
Articles
XinYaohui Closes Two Rounds Raising Over 400 Million Yuan to Develop Advanced-Process Chip IP and Accelerate Chip Innovation
Developing advanced-process chip IP products and solutions through independent R&D, bringing new luster to China's semiconductor industry.
Gaorong Ventures wishes you a Happy Chinese New Year and great fortune in the Year of the Ox!
Spring flows eternal through the high mountains and running streams; banyan branches reach toward the sun, and all things take on new life.
Fube Biotech Closes A++ Round to Pioneer CNS Drug R&D Through Homegrown Innovation
Accelerate multiple novel neurological drug candidates into clinical trials.
Rongbao · January | E-commerce and Retail Players Build Out Origin-Region Supply Chains; Multiple Chip, AI, and Enterprise Service Firms Close New Funding Rounds
Discover and accompany creators of a beautiful life.
Hyperparameter Closes $30 Million Series A+ Round to Accelerate Game AI Expansion
Dedicated to transforming how game content is produced through artificial intelligence.
Galixir's Chengtao Li: Using AI to Find the 'Key' to Curing Diseases in the Universe of Compounds | Ronghui
How artificial intelligence technology is accelerating drug discovery and development.
Xinhuazhang, an EDA company, announced the completion of its Series A+ funding round to accelerate R&D progress on EDA 2.0.
Building EDA 2.0 technology for a digital society, defining an intelligent future from the chip up.
Shexu Technology Raises Tens of Millions of RMB in Angel Round to Build Industrial Intelligent Design and Manufacturing Cloud Platform
AI + SaaS, making industrial design smarter.
Gaorong Bulletin · December | Multiple Gaorong Ventures Portfolio Companies Secure New Funding in Chips, Robotics, AI Drug Discovery, New Brands, and Other Sectors
Stepping into 2021.